Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Evenamide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Newron to Present Evenamide Data for Schizophrenia at 2025 WCBP
    Newron to Present Evenamide Data for Schizophrenia at 2025 WCBP

    05 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-05/newron-to-present-data-and-updates-on-its-clinical-program-evaluating-evenamide-as-an-add-on-treatme

    PHARMAWEB
    05 Sep 2025
    Share Share
    Newron Preclinical Data: Evenamide May Ease Schizophrenia
    Newron Preclinical Data: Evenamide May Ease Schizophrenia

    11 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250811493586/en/Newron-Notes-the-Publication-of-New-Preclinical-Research-Suggesting-Evenamide-Ameliorates-Schizophrenia-Related-Dysfunction

    BUSINESSWIRE
    11 Aug 2025
    Share Share
    Newron Preclinical Data: Evenamide Aids Schizophrenia
    Newron Preclinical Data: Evenamide Aids Schizophrenia

    11 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-11/newron-notes-the-publication-of-new-preclinical-research-suggesting-evenamide-ameliorates-schizophre

    PHARMAWEB
    11 Aug 2025
    Share Share
    Newron's Evenamide Approved for Phase III ENIGMA-TRS Program
    Newron's Evenamide Approved for Phase III ENIGMA-TRS Program

    12 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250512167812/en/Newron-Announces-Approval-for-Pivotal-Phase-III-ENIGMA-TRS-Program-With-Evenamide-as-Add-on-Therapy-in-Patients-With-Treatment-resistant-Schizophrenia-TRS

    BUSINESSWIRE
    12 May 2025
    Share Share
    Newron & Myung In Pharm Announce Agreement for evenamide in Korea
    Newron & Myung In Pharm Announce Agreement for evenamide in Korea

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109233767/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share
    Newron presents H1 2024 results and provides business update
    Newron presents H1 2024 results and provides business update

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919982611/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share